These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3006933)

  • 21. N-formimidoyl-thienamycin and norfloxacin against multiple-resistant Pseudomonas aeruginosa strains. Combined in vitro activity and comparison with 14 other antibiotics.
    Martino P; Venditti M; Valente B; Brandimarte C; Serra P
    Drugs Exp Clin Res; 1985; 11(4):247-51. PubMed ID: 3939121
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Bacteriostatic and bactericidal effect of cefotaxime combinations on Staphylococcus aureus assessed by FIC and FBC-index determination].
    Reynaud A; Drugeon HB; Courtieu AL
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):545-9. PubMed ID: 3911153
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro activity of aminoglycosides, ureidopenicillins and cephalosporins against P. aeruginosa isolated in Kuala Lumpur.
    Ngeow YS; Puthucheary SD; Lai PS
    Med J Malaysia; 1985 Sep; 40(3):196-201. PubMed ID: 3939567
    [No Abstract]   [Full Text] [Related]  

  • 24. In vitro susceptibility of Brucella melitensis to new cephalosporins crossing the blood-brain barrier.
    Palenque E; Otero JR; Noriega AR
    Antimicrob Agents Chemother; 1986 Jan; 29(1):182-3. PubMed ID: 3729331
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Susceptibility of Nocardia asteroides to 46 antibiotics, including 22 beta-lactams.
    Gutmann L; Goldstein FW; Kitzis MD; Hautefort B; Darmon C; Acar JF
    Antimicrob Agents Chemother; 1983 Feb; 23(2):248-51. PubMed ID: 6340602
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro antibacterial activities of eleven antibiotics against S. faecalis.
    Hartzen SH; Frimodt-Möller N; Andreasen JJ
    APMIS; 1988 Jul; 96(7):584-8. PubMed ID: 3136781
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Antibacterial activity of netilmicin in combination with other antibiotics. Comparison with other aminoglycosides (author's transl)].
    Cluzel M; Sirot J; Chanal M; Sirot D; Roussanne MC
    Pathol Biol (Paris); 1982 Jun; 30(6):376-9. PubMed ID: 7050845
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative activity of cefotetan against plasmid-encoded aminoglycoside-resistant enterobacteria strains.
    Gomez-Lus R; Otal I; Gomez-Lus ML; Sarraseca C; Castillo J; Gil J; Rubio MC
    Chemioterapia; 1988 Aug; 7(4):267-70. PubMed ID: 3180307
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unpredictable interactions between cefotetan and penicillins or aminoglycosides.
    Barry AL; Packer RR; Jones RN
    Diagn Microbiol Infect Dis; 1984 Sep; 2(4):347-51. PubMed ID: 6593145
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antimicrobial susceptibility of clinical isolates of Brucella.
    Mortensen JE; Moore DG; Clarridge JE; Young EJ
    Diagn Microbiol Infect Dis; 1986 Jul; 5(2):163-9. PubMed ID: 3720265
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro bactericidal activity of aminoglycosides, including the next-generation drug plazomicin, against Brucella spp.
    Olsen SC; Carlson SA
    Int J Antimicrob Agents; 2015 Jan; 45(1):76-8. PubMed ID: 25459738
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The effect of the in-vitro interaction of antibacterial preparations on Brucella melitensis].
    Samarina IV; Taran IF; Proskurina VA
    Antibiot Khimioter; 1993 Dec; 38(12):18-20. PubMed ID: 8085903
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In-vitro susceptibility of thirty strains of Haemophilus ducreyi to several antibiotics including six cephalosporins.
    Sanson-Le Pors MJ; Casin I; Ortenberg M; Perol Y
    J Antimicrob Chemother; 1983 Mar; 11(3):271-80. PubMed ID: 6601649
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Br. ovis sensitivity to antibiotics].
    Pinigin AF; Petukhova OS; Kalinovskiĭ AI; Repina LP; Laukner IV
    Antibiotiki; 1977 Aug; 22(8):716-8. PubMed ID: 907324
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro susceptibilities of nonfermentative gram-negative bacilli other than Pseudomonas aeruginosa to 32 antimicrobial agents.
    Fass RJ; Barnishan J
    Rev Infect Dis; 1980; 2(6):841-53. PubMed ID: 7012987
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measurement of levels of aminoglycosides and vancomycin in serum in the presence of new beta-lactam antibiotics.
    Calderwood SB; Tung CC; Jackson E
    J Clin Microbiol; 1984 May; 19(5):707-9. PubMed ID: 6330168
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Characteristics of etiotropic therapy of plaque infection induced by atypical strains of F1- phenotype plaque microbe].
    Ryzhko IV; Samokhodkina ED; Tsuraeva RI; Shcherbaniuk AI; Tsetskhladze NS
    Antibiot Khimioter; 1998; 43(9):24-8. PubMed ID: 9791683
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Study on antimicrobial susceptibility of Brucella in a city].
    Zuo SW; Ni ZL; Yao YB; Yang RS; Wang SK; Zhou YH
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2017 Dec; 35(12):939-941. PubMed ID: 29495161
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparative in vitro study of SQ26,776.
    Fainstein V; Weaver S; Bodey GP
    Antimicrob Agents Chemother; 1982 Feb; 21(2):294-8. PubMed ID: 6918206
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [In-vitro microbiological evaluation of the action of gentamicin and sisomicin o schizomycetes of the Salmonella genus].
    Martinetto P; Martinotti MG; Michelone G; Cappuccinelli P
    G Batteriol Virol Immunol; 1976; 69(7-12):271-9. PubMed ID: 1028649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.